Navigation Links
Savara Pharmaceuticals Appoints Two New Members to Its Board of Directors
Date:12/5/2013

AUSTIN, Texas, Dec. 5, 2013 /PRNewswire/ -- Savara Pharmaceuticals announced today that the company has appointed Dr. Joseph S. McCracken, DVM and Yuri Pikover to its Board of Directors.

Dr. McCracken has more than 25 years of experience in technical, business development and market development roles with biotechnology and pharmaceutical companies. Most recently he was Global Head of Business Development & Licensing at Roche Pharmaceuticals where he was responsible for Roche's global in-licensing and out-licensing activities. Prior to joining Roche, Dr. McCracken held the position of Vice President of Business Development at Genentech for more than a decade.

Mr. Pikover is a Managing Director of 37 Technology Ventures, a boutique venture fund focusing on growing startups, and currently serves on the boards of numerous companies. From 1993 to 2008, he founded and held executive roles at Xylan, Access360, 5square and Folsom Lake Nissan, and served on the boards of several dozen companies. Prior to 1993, Yuri held technical and management positions with Micom Systems and Fibermux Corporation.

"We are delighted to welcome Joseph and Yuri to our Board of Directors at an exciting time for the company," said Rob Neville, CEO, Savara Pharmaceuticals. "The two bring a breadth of business development and public company experience to our team that will help achieve our long term growth objectives."

Last April, Savara Pharmaceuticals announced the initiation of a Phase 2 clinical trial evaluating the safety and efficacy of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis (CF) patients. AeroVanc is the first inhaled antibiotic being developed to address the growing population of MRSA lung-infected CF patients.

Abo
'/>"/>

SOURCE Savara Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
2. Savara Pharmaceuticals AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
3. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
4. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
5. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... New York , July 29, 2015 ... by Transparency Market Research " Active Pharmaceutical Ingredients (API) ... and Forecast 2014 - 2020 " the global active ... in 2013 and is anticipated to reach USD 185.9 ... during the forecast period from 2014 to 2020. ...
(Date:7/29/2015)... , July 24, 2015 Research ... addition of the "Global Wound Care Markets ... United States, Japan, Canada, China, India, Brazil, Australia, ... The report provides a competitive market ... terms of both product offerings and product maturity. ...
(Date:7/29/2015)... YORK , July 29, 2015 /PRNewswire/ ... a new research report "Global Industry Insight: ... to 2020" with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... http://photos.prnewswire.com/prnh/20150727/756778 ) Microfluidic devices  ...
Breaking Medicine Technology:Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 2Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 4Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 5Global Wound Care Markets 2015 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 3Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 4Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 5
... PARK, Calif., March 22, 2011 Telome Health, Inc. ... property portfolio. THI will provide telomere length data from ... health monitoring. THI leverages the predictive ... protective caps at the ends of chromosomes, to assess ...
... MOUNT PROSPECT, Ill., March 22, 2011 The National Association ... the prescription monitoring programs (PMPs) of North Dakota , ... agreements to participate in the PMP Interconnect ™ system, ... United States to be linked, providing a more effective means ...
Cached Medicine Technology:Telome Health, Inc. Launches With Exclusive IP Portfolio 2Telome Health, Inc. Launches With Exclusive IP Portfolio 3Three States Sign on to Participate in NABP's Interconnected Prescription Monitoring System 2Three States Sign on to Participate in NABP's Interconnected Prescription Monitoring System 3
(Date:7/29/2015)... Aliso Viejo, CA (PRWEB) , ... July 29, 2015 , ... ... rotating wipe animations. Designed as drag & drop presets for FCPX, these transitions are ... direction controls, which add versatility to each transition. With over 60 preset styles, kinetic ...
(Date:7/29/2015)... ... July 29, 2015 , ... Toronto native Douglas James ... Dr. Cottrell has been making predictions about the economy, politics, social issues, as ... these prognostications. He warns that extreme weather conditions and increased earthquake / volcanic ...
(Date:7/29/2015)... ... , ... The Woodlands and Spring Fit Body Boot Camps have implemented an ... each month. The new system will track each time a client uses social media ... facility, the boot camps will donate 20 cents to a selected charity. , Fit ...
(Date:7/29/2015)... ... 2015 , ... People that are passionate about gardening and those that have ... “garden tower” and enhanced mineral product for growing ideal crops. , The ... balcony, or rooftop – can hold up to 100 plants in just 4 square ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth Callahan, ... Sarasota to be chosen by the manufacturer to offer and perform Kybella™ ... non-invasive way to treat and eliminate double chin fat,” Dr. Callahan explained. “Previously ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3
... Enrollment under way for individual sessions or 14-week ... 12 The Center for Autism and Related ... a new 14-part educational series for parents of ... Disorder (ASD). This includes children with Asperger,s Disorder, ...
... supplements that long, research shows , , TUESDAY, May 12 (HealthDay ... conception, folic acid supplements can help reduce the chance of ... Texas researchers say. , Their study, published in the May ... to a reduction in the odds of giving birth before ...
... May 11, 2009 Dental implants are frequently used ... restore the patient,s tooth function and appearance. Previous research ... the host tissue in the area of the implant, ... maintain the patient,s bone and gum tissue surrounding the ...
... against bird and seasonal flu viruses , ... at the Dana-Farber Cancer Institute and the Centers ... of human monoclonal antibodies that neutralize an unprecedented ... A (H5N1) virus, previous pandemic influenza viruses and ...
... - Marketed as Align(R) ... Alimentary Health Ltd. ("Alimentary Health" or "the ... its,licensing partner Procter & Gamble (P&G), that Align, ... against episodic digestive,upsets, is now available nationwide in ...
... to those needing to work from home or ... Ericom Software, a global leader in Application ... remote access solution, PowerTerm WebConnect can significantly reduce ... loss during disaster situations, such as an H1N1 ...
Cached Medicine News:Health News:Education Series Offered For Parents Of Children Diagnosed With An Autism Spectrum Disorder 2Health News:Placement of dental implants results in minimal bone loss 2Health News:Recent developments at Burnham Institute for Medical Research, May 2009 2Health News:Recent developments at Burnham Institute for Medical Research, May 2009 3Health News:Recent developments at Burnham Institute for Medical Research, May 2009 4Health News:Recent developments at Burnham Institute for Medical Research, May 2009 5Health News:Alimentary Health's Probiotic Technology Launched Nationwide in the US 2Health News:Alimentary Health's Probiotic Technology Launched Nationwide in the US 3Health News:Alimentary Health's Probiotic Technology Launched Nationwide in the US 4Health News:Ericom's Remote Access and Business Continuity Solution Increases Immunity to Productivity Losses -- Combats Swine Flu Scare 2Health News:Ericom's Remote Access and Business Continuity Solution Increases Immunity to Productivity Losses -- Combats Swine Flu Scare 3
... The PANBIO Inc. Indirect Fluorescence ... IgG Antibody is intended for the ... (Immunoglobulin G) antibody to nDNA in ... antibody in humans can be used ...
Anti-Tg and Anti-TPO are two major autoantibodies implicated in autoimmune related thyroiditis and aid in the differential diagnosis of Hashimoto's thyroiditis and Graves' disease....
... VerifyNow IIb/IIIa Assay is an automated, turbidimetric, ... function based upon the ability of activated ... The detection well of the VerifyNow IIb/IIIa ... reagents to perform this analysis. Within the ...
The Wide Angle Twin Mag NP combines the performance of two instruments to deliver unequalled power and versatility into the hands of eye care professionals....
Medicine Products: